These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4174657)

  • 1. [The fibrinolytic actiity of urine and its susceptibility to natural and synthetic antifibrinolytic agents].
    Vogel G; Sundermann A; Kresch K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):182-6. PubMed ID: 4174657
    [No Abstract]   [Full Text] [Related]  

  • 2. Antifibrinolytic drugs in the treatment of urinary tract haemorrhage.
    Andersson L
    Prog Surg; 1972; 10():76-93. PubMed ID: 4670671
    [No Abstract]   [Full Text] [Related]  

  • 3. [The significance of local fibrinolysis increase in symptomatic hematuria and its inhibition by p-aminomethylbenzoic acid].
    Hellinger J
    Z Urol Nephrol; 1966 Sep; 59(9):633-9. PubMed ID: 5997446
    [No Abstract]   [Full Text] [Related]  

  • 4. [Etiology and treatment of hematuria in hemophiliacs].
    István L
    Orv Hetil; 1972 Oct; 113(41):2458-61. PubMed ID: 5080117
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the use of antifibrinolytic agents in urology].
    Rosdy E; Biró J; Szendröi Z; Szabó V
    Acta Chir Acad Sci Hung; 1969; 10(1):25-35. PubMed ID: 5800598
    [No Abstract]   [Full Text] [Related]  

  • 6. [Some clinical experiences of "DV-79 (trans-AMCHA)" in urological diseases].
    Sugiura H
    Hinyokika Kiyo; 1966 Jan; 12(1):82-7. PubMed ID: 5950238
    [No Abstract]   [Full Text] [Related]  

  • 7. [Urinary mucoproteins. Correlation between urinary mucoproteins and urokinase activity].
    Saito H
    Nihon Hinyokika Gakkai Zasshi; 1972 Apr; 63(4):248-54. PubMed ID: 5065457
    [No Abstract]   [Full Text] [Related]  

  • 8. [Renal hemorrhage caused by a presumable rise of urokinase activity].
    Vogel G; Sundermann A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 85(1):70-3. PubMed ID: 4165542
    [No Abstract]   [Full Text] [Related]  

  • 9. [PAMBA prophylaxis in prostatectomies].
    Neef H; Preusser KP; Anger G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):197-202. PubMed ID: 4174659
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the nature orf blood coagulation factors in the human urine].
    Kuznik BI; Kalikhman IaL
    Vopr Med Khim; 1968; 14(5):503-5. PubMed ID: 5727583
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA.
    Andersson L; Nilsoon IM; Colleen S; Granstrand B; Melander B
    Ann N Y Acad Sci; 1968 Jun; 146(2):642-58. PubMed ID: 5254275
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of PAMBA in urology].
    Hellinger J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):187-96. PubMed ID: 4174658
    [No Abstract]   [Full Text] [Related]  

  • 13. [Variations of hematic fibrinolytic activity in the course of urologic surgical interventions and its treatment].
    De Sanctis S; Spampinato N; Pica M
    Minerva Anestesiol; 1965 Nov; 31(11):547-9. PubMed ID: 5884433
    [No Abstract]   [Full Text] [Related]  

  • 14. [Investigations on the fibrinolytic activity of human urine. 3. Effect of hyperbaric oxygen on the fibrinolytic activities in blood and urine].
    Sugiura H; Suzuki S; Kato S
    Nihon Hinyokika Gakkai Zasshi; 1972 Jan; 63(1):43-56. PubMed ID: 4259205
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fibrinolytic bleedings in urology].
    Lipsky H; Hubmer O
    Z Urol Nephrol; 1969; 62(6):453-61. PubMed ID: 5314209
    [No Abstract]   [Full Text] [Related]  

  • 16. [Natural and synthetic protease inhibitors as antifibrinolytic agents. Discussion].
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):244-52. PubMed ID: 4174665
    [No Abstract]   [Full Text] [Related]  

  • 17. [Exercise and fibrinolytic enzyme system. II. The fibrinolytic activities of the fresh urine and the pH2-treated urine and the urokinase].
    Kono N; Matsuzaki S
    Nihon Hinyokika Gakkai Zasshi; 1969 Jun; 60(6):529-40. PubMed ID: 5817249
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative clinical-pharmacological studies on synthetic antifibrinolytic agents].
    Markwardt F; Klöcking HP; Landmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):78-83. PubMed ID: 4189376
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of plasminogen activators by naturally occurring inhibitors in man.
    Aoki N; Kawano T
    Am J Physiol; 1972 Dec; 223(6):1334-7. PubMed ID: 4641625
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fibrinolytic and antifibrinolytic treatment].
    Sterkowicz S
    Wiad Lek; 1968 Jun; 21(12):1035-41. PubMed ID: 4875370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.